C. Iadecola

Neurology · 2002–2020

A researcher in the Science corpus: 18 papers; trusts 67 researchers and is trusted by 49 researchers here, as inferred from the citation graph.

Subfields

Whom C. Iadecola trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. David Attwell
  2. Berislav Zlokovic
  3. Ae Young Lee
  4. Joanna M. Wardlaw
  5. Peter Carmeliet
  6. B. Trapp
  7. Robin J. M. Franklin
  8. Julia J. Harris
  9. Jeffrey J. Iliff
  10. A. Armulik

Who trusts C. Iadecola overall

  1. Melanie D. Sweeney
  2. Berislav Zlokovic
  3. Axel Montagne
  4. Praveen Ballabh
  5. Elizabeth M. C. Hillman
  6. N. Abbott
  7. E. Hamel
  8. Richard N. Henson
  9. Yuanyuan Ma
  10. A. Sagare

Papers from C. Iadecola's perspective

Ordered by how strongly the researchers C. Iadecola trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Control of microglial neurotoxicity by the fractalkine receptor (Nature Neuroscience)
  2. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (Lancet Neurology)
  3. Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery (Nature Medicine)
  4. Bidirectional control of CNS capillary diameter by pericytes (Nature)
  5. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. (Journal of Clinical Investigation)
  6. ATP mediates rapid microglial response to local brain injury in vivo (Nature Neuroscience)
  7. NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease (Alzheimer's & Dementia)
  8. Neural Activity Triggers Neuronal Oxidative Metabolism Followed by Astrocytic Glycolysis (Science)
  9. Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease (Journal of Neuroscience)
  10. The amyloid hypothesis of Alzheimer's disease at 25 years (EMBO Molecular Medicine)

Their papers